Combinatorial therapy in tumor microenvironment: Where do we stand?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combinatorial therapy in tumor microenvironment: Where do we stand?
Authors
Keywords
Tumor microenvironment, Combination therapy, Hallmarks, Chemoresistance, Targeted therapies
Journal
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1876, Issue 2, Pages 188585
Publisher
Elsevier BV
Online
2021-07-02
DOI
10.1016/j.bbcan.2021.188585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Artificial Intelligence for Histology-Based Detection of Microsatellite Instability and Prediction of Response to Immunotherapy in Colorectal Cancer
- (2021) Lindsey A. Hildebrand et al. Cancers
- Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma
- (2021) Agrima Mian et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Macrophages and Extracellular Matrix in Breast Cancer: Partners in Crime or Protective Allies?
- (2021) Claire Deligne et al. Frontiers in Oncology
- Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial
- (2020) A.S. Mansfield et al. ANNALS OF ONCOLOGY
- Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma
- (2020) Chenxi Tian et al. CANCER RESEARCH
- A novel tumour suppressor lncRNA F630028O10Rik inhibits lung cancer angiogenesis by regulating miR‐223‐3p
- (2020) Limei Qin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The significance of exosomes in the development and treatment of hepatocellular carcinoma
- (2020) Xin Li et al. Molecular Cancer
- The functional activity of E-cadherin controls tumor cell metastasis at multiple steps
- (2020) Tae-Young Na et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers
- (2020) Rui Wei et al. Analytical Cellular Pathology
- ImmuCellAI: A Unique Method for Comprehensive T‐Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy
- (2020) Ya‐Ru Miao et al. Advanced Science
- HSulf‑1 and palbociclib exert synergistic antitumor effects on RB‑positive triple‑negative breast cancer
- (2020) Fengxia Chen et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Exosomal miRNAs in tumor microenvironment
- (2020) Shiming Tan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clinical utility of the exosome based ExoDx Prostate(IntelliScore) EPI test in men presenting for initial Biopsy with a PSA 2–10 ng/mL
- (2020) Ronald Tutrone et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Network-Based Single-Cell RNA-Seq Data Imputation Enhances Cell Type Identification
- (2020) Maryam Zand et al. Genes
- The roles of tumor-associated macrophages in tumor angiogenesis and metastasis
- (2020) Luo-Qin Fu et al. CELLULAR IMMUNOLOGY
- Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword
- (2020) Anthony M. Battram et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
- (2020) Alba Rodriguez-Garcia et al. Frontiers in Immunology
- FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer
- (2020) Sonia Zaghdoudi et al. EMBO Molecular Medicine
- Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment
- (2020) Valeria De Pasquale et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of microenvironment in tumor angiogenesis
- (2020) Xianjie Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
- (2020) Thomas Yau et al. JAMA Oncology
- CAR-NK cells: A promising cellular immunotherapy for cancer
- (2020) Guozhu Xie et al. EBioMedicine
- The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis
- (2020) Theresa D. Ahrens et al. Frontiers in Cell and Developmental Biology
- Tumor-Associated Neutrophils and Macrophages—Heterogenous but Not Chaotic
- (2020) Ling Wu et al. Frontiers in Immunology
- Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial
- (2019) Arnaud Scherpereel et al. LANCET ONCOLOGY
- Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
- (2019) Vicky Makker et al. LANCET ONCOLOGY
- Surgical Resection of SCLC: Prognostic Factors and the Tumor Microenvironment
- (2019) Xiaoliang Zhao et al. Journal of Thoracic Oncology
- Targeting Tumor Microenvironment for Cancer Therapy
- (2019) Catarina Roma-Rodrigues et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer
- (2019) Steven Feins et al. AMERICAN JOURNAL OF HEMATOLOGY
- Reassessment of Exosome Composition
- (2019) Dennis K. Jeppesen et al. CELL
- Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
- (2019) Howard West et al. LANCET ONCOLOGY
- Determining cell type abundance and expression from bulk tissues with digital cytometry
- (2019) Aaron M. Newman et al. NATURE BIOTECHNOLOGY
- Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology
- (2019) Racheal G. Akwii et al. Cells
- The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System
- (2019) Elisabetta Romeo et al. Cells
- Computational approaches for characterizing the tumor immune microenvironment
- (2019) Candace C. Liu et al. IMMUNOLOGY
- Biology and Role of Extracellular Vesicles (EVs) in the Pathogenesis of Thrombosis
- (2019) Marta Zarà et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
- (2019) Yuxin Lin et al. Journal of Hematology & Oncology
- Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
- (2019) William D Tap et al. LANCET
- Role of Surgery in Combination with Immunotherapy
- (2019) Nicholas D. Klemen et al. Surgical Oncology Clinics of North America
- Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment
- (2019) Jing Wang et al. Cancer Medicine
- Tumor-Associated Lymphatic Vessel Features and Immunomodulatory Functions
- (2019) Laure Garnier et al. Frontiers in Immunology
- Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma
- (2019) Nicholas D. Klemen et al. Journal for ImmunoTherapy of Cancer
- Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
- (2019) Chloé Laplagne et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer
- (2019) Scott Kopetz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
- (2019) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
- (2019) Lea Monteran et al. Frontiers in Immunology
- The Role of Sonic Hedgehog Signaling in the Tumor Microenvironment of Oral Squamous Cell Carcinoma
- (2019) Kiyofumi Takabatake et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
- (2019) Luis Paz-Ares et al. LANCET
- Laminin 332 in cancer: When the extracellular matrix turns signals from cell anchorage to cell movement
- (2019) Patricia Rousselle et al. SEMINARS IN CANCER BIOLOGY
- Extracellular Vesicle-derived circular RNAs confers chemoresistance in Colorectal cancer
- (2019) Kha Wai Hon et al. Scientific Reports
- Mining TCGA Database for Tumor Microenvironment-Related Genes of Prognostic Value in Hepatocellular Carcinoma
- (2019) Zhenfeng Deng et al. Biomed Research International
- Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer
- (2019) Hyung Soon Park et al. Journal for ImmunoTherapy of Cancer
- Natural Killer Cell Therapy: A New Treatment Paradigm for Solid Tumors
- (2019) Sooyeon Oh et al. Cancers
- Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications
- (2019) Sandra Grund-Gröschke et al. Cell Communication and Signaling
- Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
- (2019) Isabelle Ray-Coquard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
- (2019) Nicholas C. DeVito et al. Frontiers in Immunology
- T-Regulatory Cells In Tumor Progression And Therapy
- (2019) Amit Verma et al. Cancer Management and Research
- Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer
- (2019) Eleni-Kyriaki Vetsika et al. Cells
- A framework for analyzing DNA methylation data from Illumina Infinium HumanMethylation450 BeadChip
- (2018) Zhenxing Wang et al. BMC BIOINFORMATICS
- The extracellular matrix as a key regulator of intracellular signalling networks
- (2018) Jordan F Hastings et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
- (2018) Ashton C. Berger et al. CANCER CELL
- Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship
- (2018) Romana T. Netea-Maier et al. CANCER LETTERS
- Recovering Gene Interactions from Single-Cell Data Using Data Diffusion
- (2018) David van Dijk et al. CELL
- History, applications, and challenges of immune repertoire research
- (2018) Xiao Liu et al. CELL BIOLOGY AND TOXICOLOGY
- Bone marrow-derived inflammatory and steady state DCs are different in both functions and survival
- (2018) Wenjie Zhang et al. CELLULAR IMMUNOLOGY
- Adoptive transfer of natural killer cells in combination with chemotherapy improves outcomes of patients with locally advanced colon carcinoma
- (2018) Lingyu Li et al. CYTOTHERAPY
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Contribution of Tumor Endothelial Cells in Cancer Progression
- (2018) Kyoko Hida et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Extracellular matrix proteins as diagnostic markers of breast carcinoma
- (2018) Marta Giussani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
- (2018) Michael J. Overman et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrating single-cell transcriptomic data across different conditions, technologies, and species
- (2018) Andrew Butler et al. NATURE BIOTECHNOLOGY
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-associated neutrophils correlate with poor prognosis in diffuse large B-cell lymphoma patients
- (2018) B. Manfroi et al. Blood Cancer Journal
- CellProfiler 3.0: Next-generation image processing for biology
- (2018) Claire McQuin et al. PLOS BIOLOGY
- MHCflurry: Open-Source Class I MHC Binding Affinity Prediction
- (2018) Timothy J. O'Donnell et al. Cell Systems
- Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
- (2018) Li-Chun Lu et al. Liver Cancer
- Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
- (2018) Sandra P. D’Angelo et al. JAMA Oncology
- Inflammatory Role of Cancer-Associated Fibroblasts in Invasive Breast Tumors Revealed Using a Fibrous Polymer Scaffold
- (2018) Gowri Manohari Balachander et al. ACS Applied Materials & Interfaces
- Notch Signaling in the Tumor Microenvironment
- (2018) Olivier Meurette et al. CANCER CELL
- Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review
- (2018) Faezeh Hosseinzadeh et al. Cancer Cell International
- Multiple Biomarker Testing Tissue Consumption and Completion Rates With Single-gene Tests and Investigational Use of Oncomine Dx Target Test for Advanced Non–Small-cell Lung Cancer: A Single-center Analysis
- (2018) Tiffany M. Yu et al. Clinical Lung Cancer
- ICONIC: Biologic and clinical activity of first in class ICOS agonist antibody JTX-2011 +/- nivolumab (nivo) in patients (pts) with advanced cancers.
- (2018) Timothy Anthony Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1–Positive Lung Adenocarcinomas
- (2018) Naoya Miyashita et al. Journal of Thoracic Oncology
- Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells
- (2018) Estefanía Paula Juliá et al. Frontiers in Immunology
- Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity
- (2018) Orneala Bakos et al. Journal for ImmunoTherapy of Cancer
- The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma
- (2018) Dávid Vrábel et al. BLOOD REVIEWS
- A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
- (2018) Livnat Jerby-Arnon et al. CELL
- FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
- (2018) Maura C. O’Leary et al. CLINICAL CANCER RESEARCH
- A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma
- (2018) Jacob P. Laubach et al. CLINICAL CANCER RESEARCH
- FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
- (2018) Aviva C Krauss et al. CLINICAL CANCER RESEARCH
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Heparan sulfate as a regulator of inflammation and immunity
- (2018) Laura E. Collins et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Pembrolizumab in Combination with Ipilimumab as Second-Line or Later Therapy for Advanced Non–Small-Cell Lung Cancer: KEYNOTE-021 Cohorts D and H
- (2018) M.A. Gubens et al. LUNG CANCER
- Dimensionality reduction for visualizing single-cell data using UMAP
- (2018) Etienne Becht et al. NATURE BIOTECHNOLOGY
- Deep generative modeling for single-cell transcriptomics
- (2018) Romain Lopez et al. NATURE METHODS
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
- (2018) Qing Zhang et al. Journal of Immunology Research
- A Computational Approach Identifies Immunogenic Features of Prognosis in Human Cancers
- (2018) Malini Manoharan et al. Frontiers in Immunology
- Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment
- (2018) Yasuko Tada et al. Journal for ImmunoTherapy of Cancer
- Heparan sulfate proteoglycan – A common receptor for diverse cytokines
- (2018) Meng Xie et al. CELLULAR SIGNALLING
- Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat
- (2017) Anna Rossini et al. HEMATOLOGICAL ONCOLOGY
- The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
- (2017) Dimakatso Alice Senthebane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Exosomal proteins as potential markers of tumor diagnosis
- (2017) Aichun Li et al. Journal of Hematology & Oncology
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Proteoglycans remodeling in cancer: Underlying molecular mechanisms
- (2017) Achilleas D. Theocharis et al. MATRIX BIOLOGY
- Identifying specificity groups in the T cell receptor repertoire
- (2017) Jacob Glanville et al. NATURE
- Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations
- (2017) Susanne C van den Brink et al. NATURE METHODS
- Reversed graph embedding resolves complex single-cell trajectories
- (2017) Xiaojie Qiu et al. NATURE METHODS
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-cell epigenomics: Recording the past and predicting the future
- (2017) Gavin Kelsey et al. SCIENCE
- Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
- (2017) Elizabeth Allen et al. Science Translational Medicine
- Metabolic Interactions in the Tumor Microenvironment
- (2017) Costas A. Lyssiotis et al. TRENDS IN CELL BIOLOGY
- Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy
- (2017) Tianchi Yu et al. YONSEI MEDICAL JOURNAL
- Cancer associated fibroblasts: An essential role in the tumor microenvironment
- (2017) Leilei Tao et al. Oncology Letters
- Matrix metalloproteinase MMP9 maintains epithelial barrier function and preserves mucosal lining in colitis associated cancer
- (2017) Adani Pujada et al. Oncotarget
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Role of tumor microenvironment in tumorigenesis
- (2017) Maonan Wang et al. Journal of Cancer
- Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma
- (2017) Hiroyuki Kitano et al. Cancer Medicine
- The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
- (2017) Sourav Paul et al. Frontiers in Immunology
- A pilot trial of oral topotecan (TPT) in patients with refractory advanced solid neoplasms expressing HIF-1α.
- (2017) A. G. Duffy et al. JOURNAL OF CLINICAL ONCOLOGY
- FRED 2: an immunoinformatics framework for Python
- (2016) Benjamin Schubert et al. BIOINFORMATICS
- PD-1 blockade modulates chimeric antigen receptor (CAR)–modified T cells: refueling the CAR
- (2016) Elise A. Chong et al. BLOOD
- Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
- (2016) Annette Becker et al. CANCER CELL
- Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
- (2016) Rashmi Bharti et al. CANCER LETTERS
- Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
- (2016) Christophe Massard et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system
- (2016) Binlong Chen et al. JOURNAL OF CONTROLLED RELEASE
- Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs
- (2016) Agata Jabłońska-Trypuć et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial
- (2016) Tadeusz Robak et al. LEUKEMIA & LYMPHOMA
- Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution
- (2016) M Ryan Corces et al. NATURE GENETICS
- T cell fate and clonality inference from single-cell transcriptomes
- (2016) Michael J T Stubbington et al. NATURE METHODS
- Computational genomics tools for dissecting tumour–immune cell interactions
- (2016) Hubert Hackl et al. NATURE REVIEWS GENETICS
- mTORC1 and mTORC2 in cancer and the tumor microenvironment
- (2016) L C Kim et al. ONCOGENE
- Role of the tumor microenvironment in tumor progression and the clinical applications (Review)
- (2016) YAO YUAN et al. ONCOLOGY REPORTS
- Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment
- (2016) K.-S.N. Atretkhany et al. PHARMACOLOGY & THERAPEUTICS
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
- (2016) Megan K. Ruhland et al. Nature Communications
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
- (2016) P.-L. Chen et al. Cancer Discovery
- Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
- (2016) Leilei Tao et al. Scientific Reports
- pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens
- (2016) Jasreet Hundal et al. Genome Medicine
- Deep Learning Automates the Quantitative Analysis of Individual Cells in Live-Cell Imaging Experiments
- (2016) David A. Van Valen et al. PLoS Computational Biology
- A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
- (2016) Akio Ohta Frontiers in Immunology
- Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers
- (2016) Tuuli Ranki et al. Journal for ImmunoTherapy of Cancer
- Mesenchymal to Epithelial Transition Induced by Reprogramming Factors Attenuates the Malignancy of Cancer Cells
- (2016) Mikiro Takaishi et al. PLoS One
- mTOR and PDGF Pathway Blockade Inhibits Liver Metastasis of Colorectal Cancer by Modulating the Tumor Microenvironment
- (2015) Ryo Yuge et al. AMERICAN JOURNAL OF PATHOLOGY
- Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling
- (2015) Y.-Y. Yeh et al. BLOOD
- New horizons in tumor microenvironment biology: challenges and opportunities
- (2015) Fei Chen et al. BMC Medicine
- Immune checkpoint combinations from mouse to man
- (2015) Midan Ai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor microenvironment: Sanctuary of the devil
- (2015) Lanlan Hui et al. CANCER LETTERS
- Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression
- (2015) Rita Nahta et al. CARCINOGENESIS
- Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1–derived oncolytic immunotherapy
- (2015) Kevin J Harrington et al. Expert Review of Anticancer Therapy
- Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma
- (2015) J. G. Berdeja et al. HAEMATOLOGICA
- The role for autophagy in cancer
- (2015) Eileen White JOURNAL OF CLINICAL INVESTIGATION
- Genetic instability in the tumor microenvironment: a new look at an old neighbor
- (2015) Antonio Palumbo et al. Molecular Cancer
- Engineered materials for cancer immunotherapy
- (2015) Alexander S. Cheung et al. Nano Today
- Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes
- (2015) Sachet A Shukla et al. NATURE BIOTECHNOLOGY
- Spatial reconstruction of single-cell gene expression data
- (2015) Rahul Satija et al. NATURE BIOTECHNOLOGY
- MiXCR: software for comprehensive adaptive immunity profiling
- (2015) Dmitriy A Bolotin et al. NATURE METHODS
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Platinum-Based Chemotherapy
- (2015) E. Larkins et al. ONCOLOGIST
- Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition
- (2015) Lynnette R. Ferguson et al. SEMINARS IN CANCER BIOLOGY
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- Tissue invasion and metastasis: Molecular, biological and clinical perspectives
- (2015) W.G. Jiang et al. SEMINARS IN CANCER BIOLOGY
- The lymph node microenvironment and its role in the progression of metastatic cancer
- (2015) Ethel R. Pereira et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma
- (2015) J. G. Berdeja et al. HAEMATOLOGICA
- Neutrophils in Cancer: Two Sides of the Same Coin
- (2015) Eileen Uribe-Querol et al. Journal of Immunology Research
- Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
- (2015) Erika Héninger et al. Frontiers in Immunology
- Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment
- (2014) Mathumai Kanapathipillai et al. ADVANCED DRUG DELIVERY REVIEWS
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- OptiType: precision HLA typing from next-generation sequencing data
- (2014) András Szolek et al. BIOINFORMATICS
- Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays
- (2014) Martin J. Aryee et al. BIOINFORMATICS
- Axitinib augments antitumor activity in renal cell carcinoma via STAT3-dependent reversal of myeloid-derived suppressor cell accumulation
- (2014) Huaqin Yuan et al. BIOMEDICINE & PHARMACOTHERAPY
- Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review
- (2014) S. J. Ioannides et al. BREAST CANCER RESEARCH AND TREATMENT
- Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
- (2014) M D’Incalci et al. BRITISH JOURNAL OF CANCER
- Roles of tumor suppressors in regulating tumor-associated inflammation
- (2014) L Yang et al. CELL DEATH AND DIFFERENTIATION
- The extracellular matrix modulates the hallmarks of cancer
- (2014) M. W. Pickup et al. EMBO REPORTS
- NetTepi: an integrated method for the prediction of T cell epitopes
- (2014) Thomas Trolle et al. IMMUNOGENETICS
- Origin and pharmacological modulation of tumor-associated regulatory dendritic cells
- (2014) Hua Zhong et al. INTERNATIONAL JOURNAL OF CANCER
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Inflammation-induced DNA damage and damage-induced inflammation: a vicious cycle
- (2014) Timea Pálmai-Pallag et al. MICROBES AND INFECTION
- CAF-Secreted IGFBPs Regulate Breast Cancer Cell Anoikis
- (2014) Kelsey J. Weigel et al. MOLECULAR CANCER RESEARCH
- Metabolism of stromal and immune cells in health and disease
- (2014) Bart Ghesquière et al. NATURE
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Three-dimensional organotypic culture: experimental models of mammalian biology and disease
- (2014) Eliah R. Shamir et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Angiogenesis and the Tumor Microenvironment: Vascular Endothelial Growth Factor and Beyond
- (2014) Kriti Mittal et al. SEMINARS IN ONCOLOGY
- The Intercellular Metabolic Interplay between Tumor and Immune Cells
- (2014) Tingting Wang et al. Frontiers in Immunology
- The anticancer effects of HDAC inhibitors require the immune system
- (2014) Alison C West et al. OncoImmunology
- Statistical methods for detecting differentially methylated loci and regions
- (2014) Mark D. Robinson et al. Frontiers in Genetics
- Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes
- (2013) J. Ruan et al. BLOOD
- Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
- (2013) Y Yu et al. BRITISH JOURNAL OF CANCER
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- Targeting the Tumor Microenvironment: From Understanding Pathways to Effective Clinical Trials
- (2013) H. Fang et al. CANCER RESEARCH
- The Spleen in Local and Systemic Regulation of Immunity
- (2013) Vincenzo Bronte et al. IMMUNITY
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
- (2013) Gregg L. Semenza JOURNAL OF CLINICAL INVESTIGATION
- High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer
- (2013) Ryan O Emerson et al. JOURNAL OF PATHOLOGY
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- (2013) Kristian Cibulskis et al. NATURE BIOTECHNOLOGY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma
- (2013) Chunzhi Zhang et al. NEURO-ONCOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- IgBLAST: an immunoglobulin variable domain sequence analysis tool
- (2013) Jian Ye et al. NUCLEIC ACIDS RESEARCH
- Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
- (2013) Younghun Jung et al. Nature Communications
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors
- (2013) Ting Zhang et al. Stem Cell Research & Therapy
- Flow Cytometry Bioinformatics
- (2013) Kieran O'Neill et al. PLoS Computational Biology
- Matrix Metalloproteinases
- (2012) Laurie A. Shuman Moss et al. AMERICAN JOURNAL OF PATHOLOGY
- The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction
- (2012) Carsten Goessl et al. Annals of the New York Academy of Sciences
- Macrophages in Tumor Microenvironments and the Progression of Tumors
- (2012) Ning-Bo Hao et al. Clinical & Developmental Immunology
- Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer
- (2012) S. Cedrés et al. Clinical & Translational Oncology
- FlowRepository: A resource of annotated flow cytometry datasets associated with peer-reviewed publications
- (2012) Josef Spidlen et al. CYTOMETRY PART A
- Dendritic cell-based vaccines: barriers and opportunities
- (2012) Jessica A Cintolo et al. Future Oncology
- The extracellular matrix: A dynamic niche in cancer progression
- (2012) Pengfei Lu et al. JOURNAL OF CELL BIOLOGY
- Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
- (2012) Thomas J. Lynch et al. JOURNAL OF CLINICAL ONCOLOGY
- Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
- (2012) Silke Haubeiss et al. Molecular Cancer
- Unknown
- (2012) Salvatore Coniglio et al. MOLECULAR MEDICINE
- Inhibition of Mammary Tumor Growth Using Lysyl Oxidase-Targeting Nanoparticles to Modify Extracellular Matrix
- (2012) Mathumai Kanapathipillai et al. NANO LETTERS
- Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
- (2012) Caryn S. Ross-Innes et al. NATURE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular networks that regulate cancer metastasis
- (2012) Daniela Spano et al. SEMINARS IN CANCER BIOLOGY
- Cancer Cell Metabolism: One Hallmark, Many Faces
- (2012) Jason R. Cantor et al. Cancer Discovery
- BSmooth: from whole genome bisulfite sequencing reads to differentially methylated regions
- (2012) Kasper D Hansen et al. GENOME BIOLOGY
- MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets
- (2012) Zhen Shao et al. GENOME BIOLOGY
- Tumor Lymphangiogenesis as a Potential Therapeutic Target
- (2012) Tam Duong et al. Journal of Oncology
- Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status
- (2011) J Šímová et al. BRITISH JOURNAL OF CANCER
- Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers
- (2011) K J Harrington et al. BRITISH JOURNAL OF CANCER
- Anti-TIM3 Antibody Promotes T Cell IFN- -Mediated Antitumor Immunity and Suppresses Established Tumors
- (2011) S. F. Ngiow et al. CANCER RESEARCH
- Inhibition of Histone Lysine Methylation Enhances Cancer-Testis Antigen Expression in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer
- (2011) M. Rao et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
- (2011) S. Modi et al. CLINICAL CANCER RESEARCH
- A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment
- (2011) Shawn Rose et al. CYTOMETRY PART A
- MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
- (2011) James Finke et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Treatment Outcomes Between Concurrent Chemoradiotherapy and Combination of Surgery, Radiotherapy, and/or Chemotherapy in Stage III and IV Maxillary Sinus Cancer: Multi-Institutional Retrospective Analysis
- (2011) Jung Hun Kang et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Combination therapy: the next opportunity and challenge of medicine
- (2011) Paolo A Ascierto et al. Journal of Translational Medicine
- Combining mTor Inhibitors With Rapamycin-resistant T Cells: A Two-pronged Approach to Tumor Elimination
- (2011) Leslie E Huye et al. MOLECULAR THERAPY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epithelial-Mesenchymal Transition in tumor microenvironment
- (2011) Yingying Jing et al. Cell and Bioscience
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction
- (2010) Bernhard Mlecnik et al. BMC GENOMICS
- Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)
- (2010) Andres Forero-Torres et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Pazopanib in Renal Cell Carcinoma
- (2010) J. E. Ward et al. CLINICAL CANCER RESEARCH
- Automated segmentation of tissue images for computerized IHC analysis
- (2010) S. Di Cataldo et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
- (2010) A. McKenna et al. GENOME RESEARCH
- The multikinase inhibitor Sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE2 in murine macrophages
- (2010) Justin P. Edwards et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection
- (2010) Yi-Wei Li et al. JOURNAL OF HEPATOLOGY
- Melanoma: A model for testing new agents in combination therapies
- (2010) Paolo A Ascierto et al. Journal of Translational Medicine
- Cell type–specific gene expression differences in complex tissues
- (2010) Shai S Shen-Orr et al. NATURE METHODS
- Genomic instability — an evolving hallmark of cancer
- (2010) Simona Negrini et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma
- (2010) V. E. Kwitkowski et al. ONCOLOGIST
- Cancer Therapy Reform
- (2010) A. D. Levinson SCIENCE
- Mass Cytometry: Technique for Real Time Single Cell Multitarget Immunoassay Based on Inductively Coupled Plasma Time-of-Flight Mass Spectrometry
- (2009) Dmitry R. Bandura et al. ANALYTICAL CHEMISTRY
- Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel
- (2009) B. Nordlinger et al. ANNALS OF ONCOLOGY
- Extended kinase profile and properties of the protein kinase inhibitor nilotinib
- (2009) Paul W. Manley et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Mast cells in tumor growth: Angiogenesis, tissue remodelling and immune-modulation
- (2009) Steven Maltby et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Endothelin-1 Stimulates Lymphatic Endothelial Cells and Lymphatic Vessels to Grow and Invade
- (2009) F. Spinella et al. CANCER RESEARCH
- Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
- (2009) H. Xin et al. CANCER RESEARCH
- MicroRNAs As Novel Regulators of Angiogenesis
- (2009) Yajaira Suárez et al. CIRCULATION RESEARCH
- Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
- (2009) W. Wang et al. CLINICAL CANCER RESEARCH
- HIF-1α modulation by topoisomerase inhibitors in non-small cell lung cancer cell lines
- (2009) Yun Jung Choi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
- (2009) Daniel Hirschhorn-Cymerman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Anakinra for Rheumatoid Arthritis: A Systematic Review
- (2009) M. MERTENS et al. JOURNAL OF RHEUMATOLOGY
- The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels
- (2009) Erika Iivanainen et al. MICROVASCULAR RESEARCH
- FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme
- (2009) M. H. Cohen et al. ONCOLOGIST
- Denosumab: Anti-RANKL antibody
- (2009) Paul D. Miller Current Osteoporosis Reports
- “Re-educating” tumor-associated macrophages by targeting NF-κB
- (2008) Thorsten Hagemann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Interleukin-8 signaling attenuates TRAIL- and chemotherapy-induced apoptosis through transcriptional regulation of c-FLIP in prostate cancer cells
- (2008) C. Wilson et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11
- (2008) Claus Lundegaard et al. NUCLEIC ACIDS RESEARCH
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now